Comprehensive analysis of the role of deep inspiration breath‐hold in right‐sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery
Journal of Applied Clinical Medical Physics · 2025-09 · 26 (9)
DOI: 10.1002/acm2.70216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 21.08.2025. Verfasst von Volkan Semiz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey. Hauptthemen laut MEDLINE: Breath Holding, Organs at Risk, Unilateral Breast Neoplasms, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The deep inspiration breath‐hold (DIBH) technique, a method used to minimize radiation exposure to normal tissues in breast cancer patients, has primarily been applied to patients with left breast cancer. However, this study, with its unique focus on right breast cancer, aims to evaluate the potential benefits of DIBH on the right coronary artery (RCA), cardiac substructures, and liver dose in right breast cancer radiotherapy. Materials and Methods Forty right‐sided breast cancer patients were included in this study. Radiotherapy planning using 3D, IMRT, and VMAT was performed using both free‐breathing (FB) and DIBH techniques. Two treatment plans were generated per patient, and organ‐at‐risk (OAR) doses were compared using the Wilcoxon signed‐rank test. Patients were analyzed based on regional nodal irradiation (RNI) status.
Results
The mean radiation doses (Dmean) to the liver, ipsilateral lung, heart, and RCA region were 5.4, 15.9, 2.5, and 6 Gy with FB, decreasing to 4.6, 12.6, 1.6, and 3.6 Gy with DIBH. For the left ventricle, right ventricle, left atrium, and right atrium, the Dmean values were 1.2, 2.2, 2, and 4.6 Gy with FB, versus 0.76, 1.8 Gy, 1.2, and 3.2 Gy with DIBH. DIBH significantly reduced liver and lung doses in all patients, while heart and RCA doses reductions were observed only in those receiving RNI.
Conclusion
The use of the DIBH technique can significantly reduce radiation exposure to OARs in right‐sided breast cancer radiotherapy. Despite a slight increase in treatment duration, DIBH should be considered for right breast cancer radiotherapy to minimize radiation‐related toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
- Department of Radiation Oncology, Izmir City Hospital, Izmir, Turkey.
- Vocational School of Health Services, Dokuz Eylul University, Izmir, Turkey.
ORCID-Profile: Volkan Semiz
Zitieren
APA
Semiz, V., Aydin, B., Gulsan, D., Atac, E., Ozkaya, E., Kinay, S., Akcay, D., Kandemir, R., Can, M., & Gorken, I. (2025). Comprehensive analysis of the role of deep inspiration breath‐hold in right‐sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery. Journal of Applied Clinical Medical Physics, 26(9). https://doi.org/10.1002/acm2.70216
Vancouver
Semiz V, Aydin B, Gulsan D, Atac E, Ozkaya E, Kinay S, et al. Comprehensive analysis of the role of deep inspiration breath‐hold in right‐sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery. Journal of Applied Clinical Medical Physics. 2025;26(9). doi:10.1002/acm2.70216
BibTeX
@article{Semiz2025,
author = {Semiz, Volkan and Aydin, Barbaros and Gulsan, Dilara and Atac, Ece and Ozkaya, Ece and Kinay, Seyda and Akcay, Dogukan and Kandemir, Recep and Can, Melek and Gorken, Ilknur},
title = {Comprehensive analysis of the role of deep inspiration breath‐hold in right‐sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
volume = {26},
number = {9},
doi = {10.1002/acm2.70216}
}
EUVIMED